Two point mutations within the adducin genes are involved in blood pressure variation

G Bianchi1, G Tripodi, G Casari

  • 1Nephrology Clinic, University of Milan, San Raffaele Hospital, Italy.

Insights

Genetic mutations in the adducin protein are linked to renal hypertension in Milan hypertensive rats (MHS). These adducin gene variations influence blood pressure, offering insights into primary hypertension mechanisms.

Area of Science:

  • Genetics
  • Cardiovascular Science
  • Molecular Biology

Background:

  • The Milan hypertensive strain of rats (MHS) exhibits genetic renal hypertension with dysfunction mirroring human primary hypertension.
  • Membrane skeleton protein adducin, a heterodimer of alpha and beta subunits, is crucial for actin-spectrin assembly.
  • Previous studies confirmed MHS and MNS (normotensive control) homozygosity via genetic markers.

Purpose of the Study:

  • To investigate the association between specific point mutations in adducin genes and blood pressure regulation in the Milan rat strain.
  • To elucidate the role of adducin polymorphisms in the development of genetic hypertension.

Main Methods:

  • Multilocus minisatellite and monolocus microsatellite analyses were used to characterize MHS and MNS rat strains.
  • Sequencing identified specific amino acid differences in alpha- and beta-adducin between MHS and MNS.
  • In vitro phosphorylation studies assessed the impact of substitutions on protein kinase recognition sites.
  • An F2 generation was analyzed to correlate adducin alleles with blood pressure variations.

Main Results:

  • A point mutation in alpha-adducin (Y vs. F at position 316) and variations in beta-adducin (R/R, R/Q, Q/Q at position 529) were identified.
  • MHS rats possess Y in alpha-adducin and are homozygous for R in beta-adducin.
  • R/Q heterozygotes for beta-adducin exhibited lower blood pressure than homozygotes.
  • The Y allele in alpha-adducin significantly increased blood pressure, modulated by the beta-subunit's R allele.

Conclusions:

  • Adducin gene polymorphisms are strongly associated with blood pressure variation in the Milan rat model.
  • Specific amino acid substitutions in adducin, particularly within kinase recognition sites, contribute to genetic hypertension.
  • These findings highlight adducin as a potential factor in primary hypertension pathogenesis.

Related Concept Videos

Mutations01:39

Mutations

Overview
Comparing Copy Number Variations and SNPs02:26

Comparing Copy Number Variations and SNPs

Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Human Genetics01:28

Human Genetics

Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
Point and Frameshift Mutations01:30

Point and Frameshift Mutations

Point mutations are genetic alterations involving the change of a single nucleotide base pair in DNA. Depending on how the alteration affects protein synthesis, they can lead to various consequences.Point mutations fall into the following types:Silent mutations occur when a nucleotide change does not alter the amino acid sequence due to the redundancy of the genetic code. For instance, changing ACC to ACA still encodes threonine, leaving the protein function unaffected. This occurs because...